THNR · ARCA · ETF
Amplify Weight Loss Drug & Treatment ETF (THNR) Price, Holdings & Fees
$976.20+0.13%+$1.29End-of-day price as of Oct 9, 2026
Sample prices
Prices on this page are generated sample data for development, not real market data.
Amplify Weight Loss Drug & Treatment ETF (THNR) closed at $976.20 on Oct 9, 2026, up 0.13% from the previous close of $974.91.
Share price, past year
1Y −0.19%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $976.20 |
| Sep 30, 2026 | $984.02 |
| Aug 31, 2026 | $984.02 |
| Jul 31, 2026 | $1,017.52 |
| Jun 30, 2026 | $987.10 |
| May 29, 2026 | $953.20 |
| Apr 30, 2026 | $954.24 |
| Mar 31, 2026 | $990.97 |
| Feb 27, 2026 | $992.20 |
| Jan 30, 2026 | $1,034.47 |
| Dec 31, 2025 | $977.62 |
| Nov 28, 2025 | $966.37 |
| Oct 31, 2025 | $941.68 |
Key statistics
- Expense ratio
- —
- 52-week range
- $928.45 – $1,063.14
Fund profile
- Name
- Amplify Weight Loss Drug & Treatment ETF
- Ticker
- THNR
- Exchange
- ARCA
- Fund type
- ETF
- Fractional shares
- No
Frequently asked questions
What is THNR's price?
Amplify Weight Loss Drug & Treatment ETF (THNR) closed at $976.20 on Oct 9, 2026, up 0.13% from the previous close of $974.91.
Sources and methodology
Amplify Weight Loss Drug & Treatment ETF doesn't file N-PORT holdings reports with the SEC, so this page has no holdings. Prices are generated sample data for development. Data sources and disclosures